SCHEMBL31713745

SCHEMBL31713745

C=CC(=O)Nc1ccccc1-c1c(CC)n(CC(=O)Nc2ccc(C(F)(F)F)cc2Cl)c2nc(C3=CCOCC3)nn2c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WRN Q14191 1/20 0.59
▸ ACHE P22303 1/20 0.37
▸ POLB P06746 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ MAPT P10636 3/20 0.32
▸ HSD17B10 Q99714 2/20 0.32
▸ EGFR P00533 2/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ FGFR4 P22455 3/20 0.32
▸ KMT2A Q03164 2/20 0.31
▸ GAA P10253 2/20 0.31
▸ RORC P51449 1/20 0.31
▸ PIK3CD O00329 1/20 0.31
▸ PIK3C2B O00750 1/20 0.31
▸ PIK3CG P48736 1/20 0.31
▸ CNR2 P34972 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ RXFP1 Q9HBX9 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31713647 0.91 WRN (0.48) WRNPOLBMAPTEGFRRORC
SCHEMBL31713769 0.90 WRN (0.62) WRNACHEPOLBL3MBTL1MAPT
SCHEMBL31713849 0.88 WRN (0.52) WRNPOLBL3MBTL1MAPTEGFR
SCHEMBL31713369 0.87 WRN (0.51) WRNPOLBL3MBTL1MAPTHSD17B10
SCHEMBL31713566 0.86 WRN (0.50) WRNMAPTEGFRKMT2AMEN1
SCHEMBL31713802 0.86 WRN (0.51) WRNMAPTPIK3CDPIK3C2BPIK3CG
SCHEMBL31713820 0.84 WRN (0.48) WRNMAPTEGFRFGFR4CNR2
SCHEMBL31713758 0.84 WRN (0.50) WRNMAPTEGFRPIK3CDPIK3C2B
SCHEMBL25037213 0.84 WRN (0.69) WRNACHEPOLBL3MBTL1MAPT
SCHEMBL31394684 0.84 WRN (0.67) WRNACHEPOLBL3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333419-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF WRN INCYTE CORPORATION (US) 2025-10-30 — — US claimed
US-20250333419-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF WRN INCYTE CORPORATION (US) 2025-10-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250333419-A1 BICYCLIC COMPOUNDS AS INHIBITORS OF WRN WRN, BLM, RECQL WRN 1/4885ACHE 3755/4885POLB 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback